Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124532372 | 12453237 | 2 | F | 2016 | 20160628 | 20160609 | 20160706 | EXP | US-SA-2016SA106237 | AVENTIS | 57.00 | YR | A | F | Y | 0.00000 | 20160706 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124532372 | 12453237 | 1 | PS | APIDRA SOLOSTAR | INSULIN GLULISINE | 1 | Unknown | 10 UNITS PLUS SSI | 5F323A | 21629 | SOLUTION FOR INJECTION | TID | |||||||
124532372 | 12453237 | 2 | SS | SOLOSTAR | DEVICE | 1 | 5F323A | 0 | TID | ||||||||||
124532372 | 12453237 | 3 | C | LANTUS | INSULIN GLARGINE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124532372 | 12453237 | 1 | Type 2 diabetes mellitus |
124532372 | 12453237 | 2 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124532372 | 12453237 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124532372 | 12453237 | Blood glucose increased | |
124532372 | 12453237 | Cataract | |
124532372 | 12453237 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124532372 | 12453237 | 1 | 201603 | 0 | ||
124532372 | 12453237 | 2 | 201603 | 0 |